(ILCV) Morningstar Value - Overview
Etf: Large-Cap, Mid-Cap, Value, Equities, USA
Dividends
| Dividend Yield | 1.92% |
| Yield on Cost 5y | 3.21% |
| Yield CAGR 5y | -1.25% |
| Payout Consistency | 96.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 11.1% |
| Relative Tail Risk | 2.78% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.93 |
| Alpha | 6.13 |
| Character TTM | |
|---|---|
| Beta | 0.747 |
| Beta Downside | 0.806 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.95% |
| CAGR/Max DD | 1.13 |
Description: ILCV Morningstar Value January 20, 2026
The iShares Morningstar Value ETF (ILCV) seeks to track an index of U.S. large-mid cap stocks that Morningstar classifies as having above-average value characteristics. At least 80 % of the fund’s assets must be held in the index’s component securities or in securities that are “substantially identical” in economic terms, ensuring tight tracking error.
Key quantitative details (as of Q4 2025): the fund carries a net expense ratio of 0.18 %, manages roughly $3.2 billion in assets, and delivers a trailing 12-month dividend yield of about 2.4 %. Its top ten holdings-primarily in financials, industrials, and consumer staples-represent roughly 45 % of total assets, with the sector breakdown skewed toward banks (≈ 20 %) and energy (≈ 12 %). The ETF’s price-to-earnings (P/E) multiple sits near 13×, roughly 15 % lower than the S&P 500, reflecting its value tilt.
Macro-level drivers that tend to benefit ILCV include a flattening yield curve and moderate inflation, which support the profitability of cyclical and dividend-paying firms. Conversely, a rapid rise in short-term rates could compress the valuation gap between value and growth stocks, pressuring the ETF’s performance relative to growth-focused peers.
If you want a deeper, data-driven view of how ILCV fits into a broader value-oriented strategy, a quick look at ValueRay’s interactive screening tools can help you uncover hidden risk-return nuances.
What is the price of ILCV shares?
Over the past week, the price has changed by +1.85%, over one month by +2.27%, over three months by +7.81% and over the past year by +18.95%.
Is ILCV a buy, sell or hold?
What are the forecasts/targets for the ILCV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 115.1 | 17.3% |
ILCV Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.18b USD (1.18b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.18b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.18b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.67% (E(1.18b)/V(1.18b) * Re(8.67%) + (debt-free company))
Discount Rate = 8.67% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)